Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06205251 · ClinicalTrials.gov registry record · NA
Diaphragm Structure and Function in Childhood Cancer Survivors
A NA study of Childhood Cancer and Cancer Survivors, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT06205251: Recruiting NA study of Childhood Cancer and Cancer Survivors, sponsored by University of Maryland, Baltimore.
NCT06205251 is a NA study of Childhood Cancer and Cancer Survivors that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 13 participants, below the 1,472-participant average among 23 other Childhood Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06205251, a NA study of Childhood Cancer and Cancer Survivors, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study the feasibility of a specific training program for the breathing muscles (inspiratory muscle training) and the effects on how breathing is regulated during exercise in childhood cancer survivors.
Primary Outcome
Percentage of enrolled participants who complete the 6-week inspiratory muscle training protocol
Conditions Studied
Interventions
- DEVICE POWERbreathe Plus IMT
Study Locations (1)
Maryland
- University of Maryland, Baltimore - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06205251 shows while recruiting
NCT06205251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,472-participant average among 23 other Childhood Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Childhood Cancer appearing as the primary indexed condition, and to 1 intervention - of which POWERbreathe Plus IMT is the first listed.
NCT06205251 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06205251 about?
NCT06205251 is a clinical study titled "Diaphragm Structure and Function in Childhood Cancer Survivors". The purpose of this research is to study the feasibility of a specific training program for the breathing muscles (inspiratory muscle training) and the effects on how breathing is regulated during exercise in childhood cancer survivors.
What is the current status of trial NCT06205251?
This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2024-03-15. Estimated completion is 2025-12.
What conditions does trial NCT06205251 study?
This clinical trial studies the following conditions: Childhood Cancer, Cancer Survivors.
What interventions are being tested in trial NCT06205251?
The interventions under investigation include: POWERbreathe Plus IMT (DEVICE).
Who is sponsoring clinical trial NCT06205251?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06205251 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06205251's enrollment target sits among peer trials
13 22nd of 23 higher than 2 of 23 other Childhood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI